What is your take on this that arch posted on rb last night?
His comment about patent first publish later might explain Dr Frudakis' approach, why we haven't seen as much publishing as we would like.
But what is the implication of this "Genome Duality Principle?"
Sunnyvale, CA - September 5th, 2003 -- HelixoMetry, inc. announces "The Genome Duality Principle" by its Founder, CEO and inventor of FractoGene (Utility Patent submitted). HelixoMetry announces the core patenting phase of FractoGene accomplished. The inventor now turns both to Academia and to Industry to put forward "The Genome Duality Principle", promulgated here. The Principle attributes coding- and non-coding DNA a mutually supportive role in which neither is inferior to the other, thereby changing Genomics from a fishing expedition for fewer and fewer genes into an Information Challenge of colossal proportions to decipher the genetic code in which both "coding" and "non-coding" DNA play an essential part. The Principle is similar to von Neumann's architecture of computers where zeros and ones could either represent programs or data. The scholarly notion of The Genome Duality Principle was preceded by patenting FractoGene (as a Provisional Application in July 31st, 2002 and as a final Utility Application on July 28th, 2003 by Dr. Pellionisz), as the fractal coding in the the DNA of fractal organisms (neurons, lungs, etc.) is novel, non-obvious, and lends itself to a broad array of applications in Biotech, Nanotech and Infotech.
Sunnyvale, CA -(PRWEB) September 5th, 2003 -- HelixoMetry, Inc. http://helixometry.com announces that biophysicist Dr. András J. Pellionisz, Founder, CEO and inventor of "FractoGene" (Utility Patent Pending, http://fractogene.com) formally established "The Genome Duality Principle" - a radical paradigm-shift for the second 50 years of the "Genome Revolution". The scientific axiom will be published in the Special Issue of "The Cerebellum" (publisher Taylor & Francis, invited editor A. Pellionisz, http://fractogene.com/cerebellum/index.html) and will be presented on the Nanotechnology World Conference in an invited lecture by Dr. Pellionisz (October, 2003, Orlando, FL, http://usa-siliconvalley.com/inst/pellionisz/).
"Dualism and symmetry are profound characteristics of Nature, from matter and anti-matter, to covariant and contravariant (dual) representations of sensory and motor expressions", says Pellionisz, who won the prestigious Alexander von Humboldt Prize for Distinguished American Scientists from Germany for his pioneering Tensor Network Theory of neural nets earlier. "Von Neumann and Eugene Wigner, two of my fellow-country men spearheaded science pursuing the concept of dual representation in Nature. Dualism has always been a striking feature of the Double Helix itself, ever since its discovery 50 years ago" - he continues.
"Is the 'Genome Duality Principle' a hypothesis or is confirmed by irrefutable evidence?" - we ask. "It is surprising that the 'theory' of 'junk DNA' is not killed by hard evidence, although the Friedreich's spinocerebellar ataxia is firmly established as a deadly disease not caused by an exon, but by its first intron, a so-called 'junk DNA'. If it is 'just junk' could not cause a similar disease to Huntington's of Alzheimer's (etc), all caused by exon triplet runs. In science, facts don't kill theories, only a better theory kills an inferior conjecture. FractoGene as a mathematical explanation of 'junk DNA' relegates the notion of 'junk DNA to oblivion." - he says.
Dr. Pellionisz first raised voice that "junk DNA" may be the biggest fallacy of the Genome Revolution at the exclusive 50th Anniversary Celebration of the Double Helix in Monterey, February 2003, http://fractogene.com/thefutureoflife/ pointing out the striking parallel of zeros and ones in the computer memory either representing programs (like exons in the DNA) or data (like introns in the DNA) - a direct parallelism with von Neumann's cardinal contribution to the architecture of modern computers. There was practically nobody in the audience (that included James Watson, Francis Collins, Craig Venter and the like) who would believe that "junk DNA" was, indeed, "just junk". However, what was lacking at that time in public (with FractoGene Provisional Patent already submitted July 31st, 2002), what is the mathematical blueprint (fractals) of the encryption of DNA, with the exons (in humans, a mere 1.3% of the DNA) spelling out the protein-coding of fractal templates, while the vast majority (in humans, 98.7% of the DNA) providing the "fractal improvements".
"You had to endure a lot of flak for your ‘patent first, publish later' policy of our time" - we ask Dr. Pellionisz. "Indeed, but as sign of our times I don't take it personally. Especially since I did publish close to 120 books, chapters and scholarly articles on my mathematical (tensor geometry) explanation of the "little brain" (the cerebellum) and profited 25 cents in royalties on the patent in 1984. Understanding a good part of the brain had a substantial impact on Philosophy (spawning "Neurophilosopyhy" http://usa-siliconvalley.com/inst/pellionisz/85_churchland/85_churchland.html) and resulted in pilot projects at NASA to fly an F15 by an artificial cerebellum http://usa-siliconvalley.com/inst/pellionisz/f15neuralnet.html - but these achievements were largely intellectual, without much socio-economic impact. This time, however, the stakes for Big Pharma, Big Information Technology and Nanotechnology are just far too immense to put forward massive investments without adequate protection of their assets on a major scale. With FractoGene Provisional patent application filed by July 31st, 2002, and FractoGene Utility Patent application followed up well within the required one year, with even the business model protected by the claims, time is right now to "publish" - once the patent applications are accomplished".
"Is that also true for seeking funds for rapid development?" - we ask. "Not necessarily" - Pellionisz responds. "There is already a landslide of turning to ‘non-coding DNA' - just look at the August issue of Bio-IT Word http://www.bioitworld.com/archive/081303/horizons_aussie.html , where Ken Davies, Francis Collins, Charles Cantor and Kate Murashige discuss the explosive issue of "non-coding DNA" and its early (non-fractal) patents. FractoGene stands alone in providing a mathematical design-utility for protein-based biotech, nanotech and infotech. The interest is sufficient for a closely held enterprise. There is an immense amount of investment to create the shells of "Biopolis" and "Silicon Valley" type infrastructure all over the World, even in New Europe. HelixoMetry is positioning with FractoGene to make the most intelligent move, going with the best offer. After all, all infrastructure is empty shell without the creative minds for the next 50 years of the Genome Revolution."
Market Data 
Markets 
AI
